Over the past three decades, consensus over the potential relationship between asthma-specific inflammation and abnormality in cellular growth and neoplasm has not been reached. The debate rises from controversial, population-level evidence that has emerged from different methods, data sources and cohorts and in the lack of sufficient molecular-level understanding of the association between allergic airway inflammation and malignant transformation.
Introduction
Asthma is a common chronic disease that affects nearly 10% of the US population and is associated with annual costs of approximately 80 billion dollars [1] [2] [3] . Asthma has been linked to premature death, lower physical activity levels and comorbidities including obesity, gastroesophageal reflux, psychological problems, chronic infections, and hormonal disturbances [4] [5] [6] [7] . It has been suggested that chronic systemic inflammation contributes to the initiation and progression of asthma-induced comorbidities [8] [9] [10] . Chronic inflammation is also known for its effect on tumorigenesis and increased risk of cancer [11] [12] [13] . Accordingly, it is plausible that pathways activated in asthma contribute to cellular growth and proliferation. Therefore, an improved understanding of the potential association between asthma and neoplasms could inform both the pathobiology of chronic airway inflammation as well as the development of malignancy.
Conclusive clinical and population-level evidence of the relationship between asthma and neoplasms does not exist. A meta-analysis suggested a 1.8 fold increase in lung cancer in patients with asthma based on 18 studies conducted between 1966 to 2002 14 . A subsequent study found a protective effect of asthma on cancer mortality in a long-term, large-scale US-based cohort (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) 15 . A nationwide study in Sweden identified an increased incidence ratio of malignancies in 15 organ systems including leukemia, gastrointestinal, lung, prostate, nervous system, and thyroid gland with asthma 16 . Additional smaller scale studies have also identified a positive association between asthma and prostate cancer 17 , hematopoietic malignancies 18 and a protective effect on adenocarcinoma of the pancreas 19 . However, these studies did not discriminate between the mixed effect of COPD and chronic obstructive asthma, identified by International Classification of Disease version 9 clinical modifications (ICD9CM) code: 493.2, from allergic asthma (ICD: 493.0). Moreover, previous studies have been limited by a lack of statistical power, small sample sizes, potential biases in participant selection and exposure measurement 15, [20] [21] [22] [23] [24] , and the limited type of neoplasms that were studied. Therefore, additional studies are required to address these limitations and to evaluate associations with specific neoplasms 15, 21 .
To understand the potential association between asthma and the risk of various neoplasms, we studied two large-scale administrative, US-based cohort of over 20 million patients. We focused on the association pattern between neoplasms, three subtypes of asthma and five subtypes of COPD as coded in ICD9CM. We used methods of causal inference in high-dimensional data to generate new insights and employed standard epidemiological reasoning tools to evaluate new findings. Our studies suggest that asthma is associated with a range of benign glandular neoplasms and malignant neoplasms in other organs, especially secretory tissues. Our findings provide new information on the debated association between asthma and neoplasms.
Materials and Methods

Data Source and Preprocessing
Deidentified observational claim data from Healthcare Utilization Project(HCUP) Florida State Inpatient Database (SID) and Emergency Department Database (ED) 25 2004 to 2014 was used for primary analysis and hypothesis generation. Validations were conducted using HCUP California State Inpatient Database (SID) and Emergency Department Database (ED) 25 from 2005 to 2011. HCUP, or Healthcare Cost and Utilization Project, is a federal-state-industry partnership sponsored by the Agency for Healthcare Research and Quality 25 . The Florida and California SID contains all inpatient discharge records in community hospitals. The ED contains all visits to the affiliated emergency department that do not result in a hospitalization. HCUP includes records for all-payers, including the uninsured, and generally, include all non-Federal acute care hospitals in a state 26 . The data is a census of all discharges 27 , and together, the SID encompass about 95 percent of all U.S. community hospital discharges 28,29 30 . Each HCUP record represents a patient encounter 2 and includes demographic data, clinical diagnoses, comorbidities, procedures, total costs of hospitalization and other information from claim records. Also, HCUP has a pseudo-patient-identifier that allows connecting all encounters of each patient across the SID and ED datasets over time. The pseudo identifier, called 'VisitLink', is assigned through a verification process to ensure the correct assignment of a unique identifier to all admissions of a patient 31 .
International Classification of Diseases, Ninth Revision, Clinical Modification(ICD9CM) codes were used for the primary diagnosis and up to 24 comorbidities to identify exposures or events. Race was stratified into six categories: Black, White, Hispanic, Asian or Pacific Islander, Native American, and Other in the original HCUP data. History of smoking was identified by any primary or secondary diagnosis with the ICD9CM code of 305.1 (tobacco use disorder), 649.0 (tobacco use disorder complicating pregnancy, childbirth, or the puerperium), v15.82 (personal history of tobacco use), or 989.84 (toxic effect of tobacco). The study population included patients 18 years or older who had at least two inpatient or emergency department observations in our dataset. As our automated causal inference method uses transitions of patients between clinical conditions to build the transition network, we included patients with more than one observation. We conducted odds ratio analyses on the same population. We excluded patients with missing VisitLink information and excluded patients who died during asthma or COPD hospitalizations. Population characteristics are shown in the second column of Table 1 , and the consort diagram in Figure 1 summarizes the data preparation process.
Hypothesis Generation
Evaluation of all potential relationships between subtypes of asthma and various malignancies is not feasible due to theoretical and practical reasons. Accordingly, to limit the number of evaluations and identify more likely hypotheses, we used the Causal Inference using Composition of Transitions (CICT) method 32 . CICT is a method for generating probabilistic component causal hypotheses in a complex network of potential outcomes 33 . CICT is based on the idea that observing a population, the set and frequency of events before and after a causal event are different than for a random event. For example, observing a population and recording frequency of patients' transitions between the two consecutive diagnoses, the frequency of various diagnoses after diabetes should have a different pattern than the frequency of various diagnoses after viral respiratory infection (random event). CICT defines specific features to capture these differences in large-scale population-level data and uses supervised machine learning methods to learn the patterns specific to causal, random and effect phenomena. Next, CICT uses the learned patterns to generate hypotheses about potential causal relationships among various clinical conditions. For this study, we first created a network of patients' transitions between pairs of clinical conditions in our study population. The clinical conditions were identified using the ICD9CM code of primary diagnosis for admission. Next, CICT was applied to identify the relationships between asthma and various neoplasms. Figure 2 and Table 2 , show the CICT hypotheses related to potential asthma induced neoplasms.
Odds Ratio Analysis
To evaluate CICT generated hypotheses related to asthma and neoplasms, we used odds ratio analysis which is a measure of association. Also, to discriminate the effect of asthma and Chronic Obstructive Pulmonary Disease (COPD) case mix, we further added OR analysis for subtypes of COPD and identified neoplasms. For each exposure to one of the subtypes of asthma or COPD, we identified exposed groups as cases and matched them with a control group based on similar race, gender, age, and smoking status. Four cohorts were designed for asthma and its three subtypes 6 with ICD-9-CM codes: 493.* for combined asthma (N= 998937), 493.0 for extrinsic asthma (N= 28149), 493.2 chronic obstructive asthma for (N= 235446), and 493.9 for asthma unspecified (N= 853556). We excluded intrinsic asthma groups due to a low number of exposed patients (N= 1167, 0.12% of asthma patients) and that few or no neoplasms of interest were identified in both case and control groups. Six cohorts were designed for subtypes of COPD with ICD9CM codes: 491 for chronic bronchitis (N= 390862), 492 for emphysema (N= 97956), 494 for Bronchiectasis (N= 29539), and 496 for chronic airway obstruction, not elsewhere classified (N= 715957). Next, for each of the 17 neoplasm events suggested by CICT (Table 2 and Figure 2 ) and nine other relevant neoplasms (appendix table 2), we conducted a separate study. A total of 234 individual studies were designed between ten exposures and 26 neoplasm events.
Constructing matched control groups
In each study, the control group was drawn from subjects with no recorded code for any asthma or COPD subtypes as the primary diagnosis for hospital admission or comorbidities during the study period (2005) (2006) (2007) (2008) (2009) (2010) (2011) . To minimize the effects of confounding and to obtain an unbiased estimate of odds ratios, we matched the control group with the exposed patients in each study using coarsened exact matching (CEM) 34, 35 on baseline variables including age, gender, race, and smoking. The remaining imbalance and heterogeneity between case and control groups were assessed using the multivariate L1 metric 36 . Previous research used different user-specified criteria for L1 statistics [37] [38] [39] [40] [41] [42] . In this study, a threshold of L1 statistics less than 0.2 after CEM matching was considered as the acceptable.
Statistical analysis
Descriptive statistics of individual characteristics at baseline were calculated for the whole population, asthma subtypes cohorts, and COPD subtypes cohorts ( Table 1 ). We computed frequencies for categorical variables and means with standard deviations for continuous variables. The association between asthma and cancers was estimated using both the Cochran-Mantel-Haenszel (CMH) 43, 44 common odds ratio and pooled odds ratio over the whole cohort. We report CMH common odds ratios (ORs) and 95% confidence intervals (CIs) for 26 neoplasms (column 1 of table 3) in the ten matched case-control populations for subtypes of asthma and COPD (row 2 of table 3). A Bonferroni-holm 45 correction was applied to each asthma and COPD subtype cohort to control family-wise error rate. The significance threshold was established at P  0.o5. All statistical analyses were performed using F# and R.
Results
Our large-scale empirical study reveals that benign neoplasms of glands are more frequent in asthma. Also, it shows that COPD is associated with multiple malignancies including the wellknown connections between COPD and lung cancer. Moreover, we identified the association between subtypes of COPD and hematological and lymphatic malignancies and confirmed such relation with allergic asthma.
Among 524 neoplasms encoded in ICD9CM codes, our hypothesis generation method(CICT) suggests that twenty could be induced by subtypes of asthma ( Figure 2 , Table 2 ). We used epidemilogical reasoning methods to evaluate the 17 of CICT hypotheses along with nine other competing hypotheses suggested by pulmonology board. Accordingly, to measure the association of these twenty six neoplasms with an exposure to subtypes of asthma and COPD, four cohorts were designed for asthma and its three subtypes with ICD-9-CM codes: 493.* for combined asthma (N= 998937), 493.0 for extrinsic asthma (N= 28149, male= 31%, age= 47), 493.2 chronic obstructive asthma for (N= 235446, male= 38%, age= 65), and 493.9 for asthma unspecified (N= 853556, male= 32%, age= 48). Six cohorts were designed for subtypes of COPD with ICD9CM codes: 491 for chronic bronchitis (N= 390862, male= 48%, age=68), 492 for emphysema (N= 97956 , male= 53% , age= 68), 494 for Bronchiectasis (N= 29539, male= 39%, age= 71), and 496 for chronic airway obstruction, not elsewhere classified (N= 715957, male= 50%, age= 69) Approximately 8.4 million matched controls were included in each cohort: ICD9CM 493.0 (N= 8,398,723), 493.2 (N= 8,400,004), 493.9 (N= 8,400,004), 491 (N= 8,400,004), 492 (N= 8,397,079), 494 (N= 8,399,392), 495 (N=8,348,680), 496 (N= 8,400,004). The matching reduced L1 statistics from the range of 0.21-0.34 to less than 0.17 after matching in various cohorts of asthma and COPD, indicating the case and matched cohorts in 234 different studies are similar. 34 A total of 139,038 incident cases of neoplasms were identified among patients with exposure to asthma, and 338,418 in those exposed to COPD, and 518,138 in the control cohort that had no record of exposure to either respiratory disorders. The distributions of age, sex, race, and smoking in overall population and subtypes of asthma and COPD are shown in Table 1 . A history of asthma in 10.63% of the total included population, and a history of COPD of 6.96% was observed, consistent with national averages 3 1 46 . On average, patients with chronic obstructive asthma and subtypes of COPD tended to be older than those with neither condition, including those with extrinsic asthma. Patients with extrinsic asthma, asthma unspecified and bronchiectasis are less likely to be former smokers than patients with other subtypes of asthma and COPD. Bronchiectasis and subtypes of asthma are more likely to be women than in patients with chronic bronchitis, emphysema, and chronic airway obstruction -not elsewhere classified. Compared with healthy people with no history of asthma or COPD, patients with asthma were more likely to be older adults, females, white or black races, and smokers. Unspecified asthma was the most frequent diagnostic code and observed in 85.41%% of the asthma patients. Obstructive asthma had the highest risk of various pulmonary cancers (OR: 3.40 to 4.78), followed by unspecified asthma (OR: 1.66 to 2.18).
The CMH common OR estimates and 95% CIs are shown in Table 3 and appendix figures 2,3 for asthma, COPD, and their subtypes compared to the control cohort for individual cancers (column 1 of Table 3 ). The pooled odds ratio is shown in appendix POOLED ODDS RATIO. The pooled odds ratios are usually higher than corresponding common odds ratios. CMH common ORs is a weighted combination of ORs in balanced strata of the population. The balancing, conducted by CEM, ensures for the similarity of age, gender, race, and smoking between case and controls in each stratum. Extrinsic asthma was associated with benign neoplasms of cerebral meninges, major salivary glands, parathyroid gland, and pituitary gland and craniopharyngeal duct (OR:1.57-2.52); and with malignant neoplasms of intrahepatic bile ducts and upper-outer quadrant of female breast (OR 1.45-1.81). Extrinsic asthma shows a weak association with lung cancers compared to other exposures. Emphysema was associated with almost all neoplasms (OR 1.24 -9.94) except benign neoplasm of the pituitary gland and craniopharyngeal duct, benign neoplasm of thyroid glands, malignant neoplasm of extrahepatic bile ducts and malignant neoplasm of intrahepatic bile ducts. Also, emphysema showed the strongest association with lung cancers (OR 7.93-9.94). Chronic bronchitis and chronic airway obstruction show similar patterns of emphysema COPD regarding associated neoplasms (table 3 and appendix figure 3 ). The actual number of cases in the COPD and asthma cohort is reported in Table 4 , and the pooled odds ratio are presented in appendix table 1.
Subtypes of asthma and COPD showed a weak association with secondary, or metastatic, neoplasms (table 3 and appendix figure 2) with often slightly increased odds ratios. However, emphysema is associated with increased odds for secondary malignant neoplasm of other specified sites (ICD9CM: 198, OR: 2.27, CI: 2.20-2.33), secondary malignant neoplasm of respiratory and digestive systems (ICD9CM: 197, OR: 2.07, CI: 2.01-2.13) and secondary malignancy of intra-abdominal lymph nodes (ICD9CM: 196.2, OR: 1.24, CI: 1.15-1.34). Extrinsic asthma is associated with considerably increased odds of lymphatic and hematopoietic cancers (ICD9CM: 238.7, OR: 2.05, CI: 1.80-2.33). Subtypes of COPD are also associated with hematopoietic and lymphatic cancers (OR: 2.03-3.23).
Discussion
Evaluation of the relationship between asthma and neoplasms is a broad question that would entail the evaluation of over five thousands possible hypotheses between 514 neoplasms coded in the HCUPS administrative data and subtypes of asthma and relevant conditions.
Allergic asthma and COPD have contrasting associations with neoplasms
We found that allergic asthma is associated with a specific profile of neoplasms that is different from those found in obstructive asthma and COPD. Allergic asthma has a small or insignificant effect (CI contains one) on bronchial or lung cancer. This pattern contrasts that of COPD which shows a strong association with lung cancer, consistent with existing knowledge [47] [48] [49] . Chronic obstructive asthma, a diagnosis label for the spectrum of coexisting allergic and obstructive manifestations, followed a pattern similar to COPD. This finding may help explain some of the contradictory results described in previous studies where some showed a protective effect of asthma on multiple cancers and some showed a positive and inducing effect. Such contradictions could have raised because of the different case mix in those studies.
Allergic asthma is associated with benign glandular neoplasms
Our analysis indicates that allergic asthma is primarily associated with benign neoplasms in glandular tissues including the pituitary, thyroid, parathyroid, and salivary glands. Increased odds of neoplasia in various glands suggests that neoplasia happens in common glandular structures such as epithelium. This novel finding proposes that hormonal and metabolic disturbances such as obesity, diabetes, osteoporosis and thyroid dysfunction in asthmatic patients might be associated with specific pathway dysregulation in allergic airway inflammation and neoplastic transformation. Traditionally, diabetes, obesity, and osteoporosis have been attributed to high dose inhaled corticosteroid (ICS) and oral corticosteroid (OCS) therapy 50, 51 . Also, corticosteroids have been associated with a down-regulation of thyroid function [52] [53] [54] . However, a connection between thyroid or parathyroid neoplasms with corticosteroids has not been reported. Our findings are in line with recent studies which failed to establish an association between regular or high dose inhaled corticosteroid (ICS) and osteoporosis 55 or diabetes 56 and suggested that the chronic respiratory disease process itself could be responsible. Interestingly, in our study allergic asthma shows association with malignancies in ductal structures such as intrahepatic biliary system and breast. Chronic obstructive asthma (ICD: 493.2) is a mixed coding that covers the frequent case of patients with mixed asthma and obstructive symptoms.
COPD is associated with various malignant neoplasms
Our results on COPD subtypes and combined cohorts are consistent with existing knowledge of the increased risk of lung cancers, specifically the seven to nine-fold increase in odds of lung and bronchial cancers in the presence of emphysema. Both chronic asthma and COPD induces alveolar hypoxia, hypoxemia and consequent tissue hypoxia which also results in systemic inflammation. Recent studies have established a direct link between hypoxia and the composition and organization of the extracellular matrix (ECM). Furthermore, emerging data indicate that ECM has a crucial role in metastasis 57 . Specifically, increased expression of genes encoding proteins that mediate ECM remodeling has been associated with increased mortality in patients with breast, lung and gastric cancers [57] [58] [59] . These molecular findings are in line with our findings that show an increased risk of breast, gastrointestinal and lung cancer. However, the higher incidence of lung cancer and lower, or statistically insignificant increased, the rate of breast and gastrointestinal cancer in COPD in comparison with asthma suggests that the proinflammatory effect of COPD on ECM is local, whereas asthma induces a more systemic effect.
The increased odds of lymphatic and hematopoietic cancers in the presence of allergic asthma is confirmed in our study. These findings provide new insight into the inconclusive evidence regarding the role of asthma in lymphatic and hematopoietic cancer 60, 61 with different studies reporting highly elevated 62 to reduced risks 23 . Moreover, for the first time, we showed that the subtypes of COPD are strongly associated with hematopoietic and lymphatic cancers.
Automatic hypothesis generation accelerates research
Another significant result of this research is that we employed new approaches to machine inference to generate hypotheses from data and the standard tools of epidemiological reasoning, to validate those hypotheses. The hypotheses were generated using CICT 32 which employes supervised machine learning approach for top-down causal inference. CICT learns the features of causal relationships from labeled known causal relationships. Then it uses the learned features to predict new causal associations with high accuracy. Using CICT on Florida state data we reduced thousands of possible associations of 524 candidate neoplasms to subtypes of asthma, to only 17 promising relationships. Next, we examined those findings using California data, through creating balanced cohorts and conducting odds ratio analysis. The two-step process resulted in a targeted evaluation plus validation of just the promising hypotheses. It is important to clarify that although CICT is a method for identifying causal associations, here our epidemiological reasoning methods are meant only to validate the association claim and not the causality one. Nevertheless, the use of non-reductionist methods such as CICT helps to produce valuable insights by embracing the heterogeneity of the population, finding patterns that are otherwise unidentifiable, and increasing the external validity of those findings. We suggest that adding machine learning to our toolbox of causal inference methods can help in producing evidence in an expedient and non-expensive manner.
Large-scale observational data is an indispensable source of discovery
The vast amount of administrative data can produce valuable insights. The large volume of data when used with proper methods, can compensate for the inherent noise and help find signals that are invisible in small-scale data, limited data acquisition practices, or obsessively filtered data. In this study, we used ten years of unfiltered data from Florida State inpatient and emergency departments, to conduct causal inference and then employed six years of similar data from California State to validate our findings through 234 individual studies in ten balanced cohorts. The large-scale discovery and validation datasets helped us to bring new insights into controversies about asthma, COPD, and neoplasms.
Conclusion
The present study is the most extensive cohort reported of patients exposed to asthma or COPD. We revealed the previously unknown relation between allergic asthma and benign neoplasms of multiple glands. Also, we identified the association between subtypes of COPD and hematological and lymphatic malignancies and confirmed such relation with allergic asthma. Moreover, we discriminated the mixed signal of obstructive asthma which caused contradictory results in previous studies, probably due to selection bias, and showed that the set of neoplasms in allergic asthma and COPD have significant differences that suggest various pathway involvements.
Limitations:
The use of administrative data is constrained by the lack of clinical depth and potential coding errors. For example, an accurate specification of the onset or subtype of asthma might not be possible. Also, attributing the higher odds of benign neoplasms of glands to corticosteroids or asthma needs further investigation through clinical data. As HCUP data does not contain outpatient medical office visits, our study was limited to inpatient and emergency department records, which usually contain records for patients at a later stage or more severe condition of asthma or COPD. Nevertheless, employing proper methods on large volumes of data provides the opportunity to improve the signal to noise ratio. In this study, the large cohort population allows us to capture the relationship between allergic asthma and benign neoplasms and uncover the differences between obstructive and allergic asthma in the promotion of lung cancers.
Future studies
The molecular mechanism(s) that link asthma with its comorbidities, especially the potential connection between asthma-related dysregulations and cellular growth and neoplasms, has yet to be studied. Further epidemiological etiology research for identifying and profiling upstream and downstream causal associations of asthma can provide clues and guide systems biology level studies 5 and may help in understanding the underlying mechanisms of asthma itself. Figure 2 : Results of individual asthma-neoplasm studies. Each line fragment shows the confidence interval for the odds ratio (dot) of a specific neoplasm(rows) with subtypes of asthma(columns). Clinically significant OR that does not cross one (the blue line) are in the red. In row labels, MN stands for malignant neoplasm, and BN stands for benign neoplasm.
